Arbutus Biopharma

ABUS · NASDAQ

$4.33+$0.10 (+2.36%)TodayMarket closed ·
Prev close $4.23

Who owns ABUS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 67.7% of ABUS’s shares.

  • Roivant Sciences Ltd.19.7%
  • Two Seas Capital LP9.7%
  • Morgan Stanley Investment Management Inc. (US)8.7%
  • Whitefort Capital Management, LP8.0%
  • Next 6 largest institutions21.7%
  • All other shareholders32.3%
Top institutional holders of ABUS
HolderShares% of shares
Roivant Sciences Ltd.38.85M19.67%
Two Seas Capital LP19.10M9.67%
Morgan Stanley Investment Management Inc. (US)17.12M8.67%
Whitefort Capital Management, LP15.79M8.00%
BlackRock Institutional Trust Company, N.A.12.22M6.18%
State Street Investment Management (US)7.87M3.98%
Rubric Capital Management LP7.53M3.81%
Vanguard Capital Management, LLC7.01M3.55%
Geode Capital Management, L.L.C.4.12M2.08%
Barclays Capital Inc.4.10M2.08%

Largest mutual fund holders

Top mutual fund holders of ABUS
HolderShares% of shares
Vanguard Total Stock Market Index Fund5.03M2.55%
iShares Russell 2000 ETF4.09M2.07%
State Street SPDR S&P Biotech ETF3.88M1.96%
Morgan Stanley Insight Fund2.73M1.38%
MS INVF Global Insight Fund2.50M1.27%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of ABUS in the last 6 months.

Latest ABUS insider transactions
InsiderTypeSharesValue
Nguyen TuanOther48.08K$240.41K
Sawhney RogerOther17.14K$85.71K
Androski LindsayOther24.66K$123.28K
Beardsley Robert AOther17.95K$89.74K
Androski LindsayOption exercise10.46K—
Androski LindsayOption exercise116.41K—
Androski LindsayTax withholding82.53K$418.41K
Androski LindsayOption exercise10.46K$45.90K
Androski LindsayOption exercise116.41K$372.51K
Nguyen TuanOption exercise27.48K—

Short interest

Settled Sep 30, 2026

Shares short
34.05M
Days to cover
3.53
% of shares outstanding
17.24%
Average daily volume
9.65M
Change since last report
+84.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.